Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes

Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes.

Guardado en:
Detalles Bibliográficos
Autores principales: Shayesteh R. Ferdosi, Radwa Ewaisha, Farzaneh Moghadam, Sri Krishna, Jin G. Park, Mo R. Ebrahimkhani, Samira Kiani, Karen S. Anderson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/7163fcf8bec84bbaa28f45dd3cb383d7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7163fcf8bec84bbaa28f45dd3cb383d7
record_format dspace
spelling oai:doaj.org-article:7163fcf8bec84bbaa28f45dd3cb383d72021-12-02T15:36:18ZMultifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes10.1038/s41467-019-09693-x2041-1723https://doaj.org/article/7163fcf8bec84bbaa28f45dd3cb383d72019-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-09693-xhttps://doaj.org/toc/2041-1723Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes.Shayesteh R. FerdosiRadwa EwaishaFarzaneh MoghadamSri KrishnaJin G. ParkMo R. EbrahimkhaniSamira KianiKaren S. AndersonNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Shayesteh R. Ferdosi
Radwa Ewaisha
Farzaneh Moghadam
Sri Krishna
Jin G. Park
Mo R. Ebrahimkhani
Samira Kiani
Karen S. Anderson
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
description Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes.
format article
author Shayesteh R. Ferdosi
Radwa Ewaisha
Farzaneh Moghadam
Sri Krishna
Jin G. Park
Mo R. Ebrahimkhani
Samira Kiani
Karen S. Anderson
author_facet Shayesteh R. Ferdosi
Radwa Ewaisha
Farzaneh Moghadam
Sri Krishna
Jin G. Park
Mo R. Ebrahimkhani
Samira Kiani
Karen S. Anderson
author_sort Shayesteh R. Ferdosi
title Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
title_short Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
title_full Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
title_fullStr Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
title_full_unstemmed Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
title_sort multifunctional crispr-cas9 with engineered immunosilenced human t cell epitopes
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/7163fcf8bec84bbaa28f45dd3cb383d7
work_keys_str_mv AT shayestehrferdosi multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
AT radwaewaisha multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
AT farzanehmoghadam multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
AT srikrishna multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
AT jingpark multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
AT morebrahimkhani multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
AT samirakiani multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
AT karensanderson multifunctionalcrisprcas9withengineeredimmunosilencedhumantcellepitopes
_version_ 1718386359124623360